These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 21862409)
1. Revisiting Beta-lactams - PK/PD improves dosing of old antibiotics. MacGowan A Curr Opin Pharmacol; 2011 Oct; 11(5):470-6. PubMed ID: 21862409 [TBL] [Abstract][Full Text] [Related]
2. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183 [TBL] [Abstract][Full Text] [Related]
3. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics. Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital. Furtado GH; Cardinal L; Macedo RS; Silva JO; Medeiros EA; Kuti JL; Nicolau DP Rev Soc Bras Med Trop; 2015; 48(5):539-45. PubMed ID: 26516962 [TBL] [Abstract][Full Text] [Related]
5. Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria. Moriyama B; Henning SA; Neuhauser MM; Danner RL; Walsh TJ Ann Pharmacother; 2009 Jul; 43(7):1324-37. PubMed ID: 19584386 [TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients. Shea KM; Cheatham SC; Smith DW; Wack MF; Sowinski KM; Kays MB Ann Pharmacother; 2009 Nov; 43(11):1747-54. PubMed ID: 19809009 [TBL] [Abstract][Full Text] [Related]
7. Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. Roberts JA; Paratz J; Paratz E; Krueger WA; Lipman J Int J Antimicrob Agents; 2007 Jul; 30(1):11-8. PubMed ID: 17442541 [TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients. Rafati MR; Rouini MR; Mojtahedzadeh M; Najafi A; Tavakoli H; Gholami K; Fazeli MR Int J Antimicrob Agents; 2006 Aug; 28(2):122-7. PubMed ID: 16815689 [TBL] [Abstract][Full Text] [Related]
9. Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base. Abdul-Aziz MH; Portunato F; Roberts JA Curr Opin Infect Dis; 2020 Dec; 33(6):501-510. PubMed ID: 33009140 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units. Roos JF; Bulitta J; Lipman J; Kirkpatrick CM J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209 [TBL] [Abstract][Full Text] [Related]
14. Comparison of antimicrobial pharmacokinetic/pharmacodynamic breakpoints with EUCAST and CLSI clinical breakpoints for Gram-positive bacteria. Asín E; Isla A; Canut A; Rodríguez Gascón A Int J Antimicrob Agents; 2012 Oct; 40(4):313-22. PubMed ID: 22921422 [TBL] [Abstract][Full Text] [Related]
15. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal. Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492 [TBL] [Abstract][Full Text] [Related]
16. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics. Burgess DS; Frei CR J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664 [TBL] [Abstract][Full Text] [Related]
17. Continuous and extended infusions of β-lactam antibiotics in the pediatric population. Walker MC; Lam WM; Manasco KB Ann Pharmacother; 2012 Nov; 46(11):1537-46. PubMed ID: 23115223 [TBL] [Abstract][Full Text] [Related]
18. Prolonged Versus Intermittent Infusion of β-Lactam Antibiotics: A Systematic Review and Meta-Regression of Bacterial Killing in Preclinical Infection Models. Dhaese S; Heffernan A; Liu D; Abdul-Aziz MH; Stove V; Tam VH; Lipman J; Roberts JA; De Waele JJ Clin Pharmacokinet; 2020 Oct; 59(10):1237-1250. PubMed ID: 32710435 [TBL] [Abstract][Full Text] [Related]
19. Prolonging β-lactam infusion: a review of the rationale and evidence, and guidance for implementation. MacVane SH; Kuti JL; Nicolau DP Int J Antimicrob Agents; 2014 Feb; 43(2):105-13. PubMed ID: 24359838 [TBL] [Abstract][Full Text] [Related]
20. The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints. Stass H; Dalhoff A Infection; 2005 Dec; 33 Suppl 2():29-35. PubMed ID: 16518709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]